ClinicalTrials.Veeva

Menu

High Pressure Non Invasive Ventilation in Hypercapnic Respiratory Failure

A

Assiut University

Status

Unknown

Conditions

Acute Hypercapnic Respiratory Failure

Treatments

Device: High pressure non invasive ventilation in acute hypercapnic respiratory failure

Study type

Observational

Funder types

Other

Identifiers

NCT04362787
High pressure

Details and patient eligibility

About

High pressure NIV is a pressure limited ventilation, stating IPAP pressure at 20 cmH2O and gradually increasing pressure up to 30 cmH2O according to patient tolerance.

Full description

Noninvasive ventilation (NIV): refers to the administration of ventilatory support without using an invasive artificial airway (endotracheal tube or tracheostomy tube). NPPV is well established in the management of acute on chronic hypercapnic respiratory failure secondary to acute exacerbation of COPD (AECOPD), obesity hypoventilation syndrome, and restrictive thoracic disorders.

During the past years NIV was applied by using low pressure inspiratory positive airway pressure (IPAP), which means titrating inspiratory pressure starting at 10 cmH2O and increasing pressure gradually according to patient tolerance maximum up to 20 cm H2O.

There is still about 15% failure rate while using conventional low pressure NIV, this failure rate may be attributed to the following:

  1. Still in a number of patients with conventional low pressure NIV, PaCO2, and pH worsen with subsequent deterioration and need for invasive ventilation.
  2. Despite lowering PaCO2 value with conventional NIV ventilation but it is not normalized so with minimal derangement in clinical condition of the patient it worsens again.
  3. Also abnormally high level PaCO2 may have a negative impact on vital organs.
  4. Low pressure may be associated with patient intolerance , and discontinuation of NIV.

Recently high pressure NIV used aiming to improve outcome of NIV. High pressure NIV is a pressure limited ventilation, stating IPAP pressure at 20 cmH2O and gradually increasing pressure up to 30 cmH2O according to patient tolerance. High pressure NIV is expected to improve alveolar ventilation, decreasing dead space ventilation, and work of breathing, so it can improve the outcome result .

Enrollment

52 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

All patients admitted in Assiut University Hospital and Assiut Police Hospital with acute hypercapnic respiratory failure due to COPD and Obesity hypoventilation syndrome (OHS) indicated for conventional NIV.

Patients who failed on low pressure NIV will be shifted to high pressure NIV with any of these conditions:

  1. PH <7.30 or less than admission level.
  2. RR > 35b/m or more than admission level.
  3. SpO2 < 88%.

Exclusion criteria: (4)

  1. Age <18 years.
  2. Excessive amount of respiratory secretions or weak cough.
  3. Upper airway obstruction.
  4. Recent oral, facial or cranial trauma or surgery.
  5. Sever abdominal distension.
  6. Active upper gastrointestinal bleeding.
  7. Cardiac or respiratory arrest.
  8. PH<7.25.
  9. Arterial oxygen tension /fraction of inspired oxygen (PaO2 / FiO2) <150mmHg.

Trial design

52 participants in 1 patient group

High pressure _ low pressure non-invasive ventilation
Description:
In the high-pressure NIV,52 patients will undergo pressure-limited NPPV at a higher IPAP level. IPAP is initially set at 20 cmH2O and continuously adjusted by increments and decrements of 1-2 cmH2O (up to 30 cmH2O), according to patients' tolerance, to obtain a tidal volume (VT) of 15 mL/kg of IBW. 2- EPAP for patients with COPD will be started at EPAP 5 and will be increased till 7 and for the patients with hypoventilation syndrome will be increased up to EPAP 8. 3-Respiratory rate 10-12 b/min.
Treatment:
Device: High pressure non invasive ventilation in acute hypercapnic respiratory failure

Trial contacts and locations

0

Loading...

Central trial contact

Maha Ei Abdelhafeez, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems